iCAD Stock Forecast, Price & News

-0.66 (-4.31 %)
(As of 07/30/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume49,963 shs
Average Volume83,864 shs
Market Capitalization$366.06 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ICAD News and Ratings via Email

Sign-up to receive the latest news and ratings for iCAD and its competitors with MarketBeat's FREE daily newsletter.

iCAD logo

About iCAD

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and automated density assessment solutions, which provides automated, consistent, and standardized density assessment. It also offers ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities and calcifications in digital breast tomosynthesis; ProFound AI Risk, a tool that provides breast cancer risk estimation based on a screening mammogram; and magnetic resonance imaging applications, a tool to detect breast and prostate cancer. In addition, the company offers VeraLook, a solution designed to support the detection of colonic polyps in conjunction with CT Colonography. Further, it provides Xoft Axxent electronic brachytherapy systems for the treatment of early stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices. The company serves healthcare centers through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, and resellers. It also exports its products in Europe, Taiwan, Canada, China, and internationally. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

2.23 out of 5 stars

Computer And Technology Sector

129th out of 643 stocks

Surgical & Medical Instruments Industry

15th out of 74 stocks

Analyst Opinion: 3.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

iCAD (NASDAQ:ICAD) Frequently Asked Questions

Is iCAD a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iCAD in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" iCAD stock.
View analyst ratings for iCAD
or view top-rated stocks.

What stocks does MarketBeat like better than iCAD?

Wall Street analysts have given iCAD a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but iCAD wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is iCAD's next earnings date?

iCAD is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for iCAD

How can I listen to iCAD's earnings call?

iCAD will be holding an earnings conference call on Thursday, August 5th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were iCAD's earnings last quarter?

iCAD, Inc. (NASDAQ:ICAD) issued its earnings results on Wednesday, April, 28th. The technology company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.11) by $0.04. The technology company earned $8.64 million during the quarter, compared to analysts' expectations of $8.13 million. iCAD had a negative net margin of 23.41% and a negative trailing twelve-month return on equity of 21.51%.
View iCAD's earnings history

How has iCAD's stock price been impacted by COVID-19?

iCAD's stock was trading at $11.12 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ICAD shares have increased by 31.8% and is now trading at $14.66.
View which stocks have been most impacted by COVID-19

What guidance has iCAD issued on next quarter's earnings?

iCAD updated its first quarter 2021 earnings guidance on Tuesday, May, 4th. The company provided earnings per share (EPS) guidance of - for the period. The company issued revenue guidance of $8.10 M-, compared to the consensus revenue estimate of $7.89 million.

What price target have analysts set for ICAD?

7 brokerages have issued twelve-month price targets for iCAD's shares. Their forecasts range from $19.00 to $27.00. On average, they anticipate iCAD's share price to reach $23.00 in the next twelve months. This suggests a possible upside of 56.9% from the stock's current price.
View analysts' price targets for iCAD
or view top-rated stocks among Wall Street analysts.

Who are iCAD's key executives?

iCAD's management team includes the following people:
  • Mr. Michael S. Klein, Exec. Chairman & CEO (Age 67, Pay $621.02k)
  • Ms. Stacey M. Stevens, Pres (Age 53, Pay $484.83k)
  • Mr. Jonathan Go, Chief Technology Officer (Age 58, Pay $416.34k)
  • Mr. Charles Ross Carter, Interim Chief Financial Officer & Sec. (Age 53)
  • Ms. Annette L. Heroux, VP of Admin. (Age 64)
  • Mr. Jeffrey Sirek, Sr. VP & Gen. Mang. of Xoft

What is Michael Klein's approval rating as iCAD's CEO?

4 employees have rated iCAD CEO Michael Klein on Michael Klein has an approval rating of 75% among iCAD's employees.

Who are some of iCAD's key competitors?

What other stocks do shareholders of iCAD own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iCAD investors own include Inseego (INSG), Marvell Technology (MRVL), NVIDIA (NVDA), Aptiv (APTV), (JD), Advanced Micro Devices (AMD), Bilibili (BILI), Ambarella (AMBA), BioXcel Therapeutics (BTAI) and Telefonaktiebolaget LM Ericsson (publ) (ERIC).

What is iCAD's stock symbol?

iCAD trades on the NASDAQ under the ticker symbol "ICAD."

Who are iCAD's major shareholders?

iCAD's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Kornitzer Capital Management Inc. KS (1.64%), Calamos Advisors LLC (0.74%), GWM Advisors LLC (0.48%), We Are One Seven LLC (0.15%), Alliancebernstein L.P. (0.06%) and Cutler Group LP (0.00%). Company insiders that own iCAD stock include Andy Sassine, R Scott Areglado and Stacey M Stevens.
View institutional ownership trends for iCAD

Which major investors are selling iCAD stock?

ICAD stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, and We Are One Seven LLC. Company insiders that have sold iCAD company stock in the last year include Andy Sassine, R Scott Areglado, and Stacey M Stevens.
View insider buying and selling activity for iCAD
or view top insider-selling stocks.

Which major investors are buying iCAD stock?

ICAD stock was purchased by a variety of institutional investors in the last quarter, including Kornitzer Capital Management Inc. KS, GWM Advisors LLC, Alliancebernstein L.P., and Cutler Group LP.
View insider buying and selling activity for iCAD
or or view top insider-buying stocks.

How do I buy shares of iCAD?

Shares of ICAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iCAD's stock price today?

One share of ICAD stock can currently be purchased for approximately $14.66.

How much money does iCAD make?

iCAD has a market capitalization of $366.06 million and generates $29.70 million in revenue each year. The technology company earns $-17,610,000.00 in net income (profit) each year or ($0.43) on an earnings per share basis.

How many employees does iCAD have?

iCAD employs 113 workers across the globe.

What is iCAD's official website?

The official website for iCAD is

Where are iCAD's headquarters?

iCAD is headquartered at 98 SPIT BROOK ROAD SUITE 100, NASHUA NH, 03062.

How can I contact iCAD?

iCAD's mailing address is 98 SPIT BROOK ROAD SUITE 100, NASHUA NH, 03062. The technology company can be reached via phone at 603-882-5200 or via email at [email protected]

This page was last updated on 8/1/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.